Peyton R. Howell - 18 May 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ Rachel Malina, Attorney-in-Fact for Peyton R. Howell
Issuer symbol
TNDM
Transactions as of
18 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 20:02:20 UTC
Previous filing
10 May 2022
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1,653 +56% $0.000000 4,601 18 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +1,653 $0.000000* 0 18 May 2022 Common Stock 1,653 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company.
F3 Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.